0000899243-21-028516.txt : 20210715 0000899243-21-028516.hdr.sgml : 20210715 20210715181617 ACCESSION NUMBER: 0000899243-21-028516 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210715 FILED AS OF DATE: 20210715 DATE AS OF CHANGE: 20210715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MacBeath Gavin CENTRAL INDEX KEY: 0001738082 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 211093654 MAIL ADDRESS: STREET 1: C/O ABPRO CORPORATION STREET 2: 65 CUMMINGS PARK DRIVE CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-07-15 0 0001783328 TScan Therapeutics, Inc. TCRX 0001738082 MacBeath Gavin C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 0 1 0 0 Chief Scientific Officer Voting Common Stock 44767 D Employee Stock Option (right to buy) 1.97 2029-01-23 Voting Common Stock 35302 D Employee Stock Option (right to buy) 2.46 2029-12-17 Voting Common Stock 52575 D Employee Stock Option (right to buy) 5.82 2031-01-26 Voting Common Stock 166577 D The shares originally subject to this option vested over 4 years of service following December 3, 2018, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. In addition, all of the shares subject to this option shall vest and become fully exercisable upon a Change of Control (as defined in the option agreement). The shares originally subject to this option vested over 4 years of service following December 5, 2019, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. The shares subject to this option vest over 4 years of service following January 25, 2021, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. /s/ Gavin MacBeath 2021-07-15